coptisine has been researched along with Colorectal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, B; Huang, T; Jiang, P; Li, X; Li, Z; Ye, X; Yu, Y | 1 |
| Han, B; He, K; Huang, T; Li, L; Li, X; Ma, H; Tian, C; Wang, M; Wang, Y; Xiao, Y; Ye, X; Yi, L | 1 |
2 other study(ies) available for coptisine and Colorectal Cancer
| Article | Year |
|---|---|
Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K/Akt and mitochondrial-associated apoptotic pathway.
Topics: Animals; Apoptosis; Berberine; Cell Movement; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cytochromes c; HCT116 Cells; Humans; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction | 2018 |
Coptisine from Rhizoma Coptidis Suppresses HCT-116 Cells-related Tumor Growth in vitro and in vivo.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Araceae; Berberine; Cell Proliferation; Colorectal Neoplasms; Disease Models, Animal; HCT116 Cells; Heterografts; Humans; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Treatment Outcome | 2017 |